Back to Search Start Over

Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge.

Authors :
Vetrone L
Cuzzani G
Mei R
Zanoni L
Bertaccini A
Bianchi L
Castellucci P
Gaudiano C
Cappelli A
Giunchi F
Fanti S
Source :
Frontiers in oncology [Front Oncol] 2023 Feb 07; Vol. 13, pp. 1101221. Date of Electronic Publication: 2023 Feb 07 (Print Publication: 2023).
Publication Year :
2023

Abstract

This is a case of [ <superscript>68</superscript> Ga]Ga-Prostate-specific membrane antigen (PSMA)-11 PET/CT in a 73-years old patient presenting high Prostate Specific Antigen (PSA) levels despite both multi-parametric magnetic resonance imaging (mpMRI) and 12-core saturation biopsy negative for prostate cancer (Pca). This is a highly interesting case because, despite the advanced metastatic spread at initial presentation as showed by [ <superscript>68</superscript> Ga]Ga-PSMA-PET/CT, the primary Pca was detected by none of the diagnostic techniques (12 random sample biopsy, mpMRI, PSMA PET/CT). However, [ <superscript>68</superscript> Ga]Ga-PSMA-PET/CT showed a suspicious axillary lesion suitable for biopsy, which finally resulted as Pca metastasis. This case report is therefore a brilliant example of how [ <superscript>68</superscript> Ga]Ga-PSMA-PET/CT optimized patient's management.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Vetrone, Cuzzani, Mei, Zanoni, Bertaccini, Bianchi, Castellucci, Gaudiano, Cappelli, Giunchi and Fanti.)

Details

Language :
English
ISSN :
2234-943X
Volume :
13
Database :
MEDLINE
Journal :
Frontiers in oncology
Publication Type :
Academic Journal
Accession number :
36824128
Full Text :
https://doi.org/10.3389/fonc.2023.1101221